Press Releases

September 16th, 2022

TORONTO, September 16, 2022 – Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) announces that the Toronto Stock Exchange (“TSX”) issued a decision today to extend its delisting review period until November 29, 2022.  The Company will provide further updates as warranted.   For Investor & […]

August 11th, 2022

31% increase in branded cannabis net revenue[1] to $10.0 million from $7.6 million in the prior year #12 ranking for market share in core markets[2] for Q1 FY2023 In the Ontario value category, Divvy has attained #5 market share in pre-roll and #7 in flower Secured new international partnership representing approximately $4.6 million sales commitment […]

August 4th, 2022

TORONTO, August 4, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on August 11 prior to market open its fiscal year 2023 first quarter results for the period ending June 30, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]

June 28th, 2022

TORONTO, June 28, 2022 — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced amendment of its unsecured convertible debentures (the “Debenture Amendments”).   “We are delighted we have now completed this transaction,” said Tricia Symmes Aleafia Health’s CEO.  “We want […]

June 28th, 2022

151% increase in branded cannabis net revenue[1] to $36.8 million in 15-month fiscal year 2022 ended March 31, 2022 (new fiscal year end) from $14.6 million in the prior 12-month year $8 million in branded cannabis net revenue for Q5, a growth of 55% calendar year over calendar year 3rd highest increase in overall market […]

June 24th, 2022

TORONTO, June 24, 2022 — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced private placement (the “Private Placement”) representing aggregate gross proceeds of approximately $5.6 million. Pursuant to the Private Placement, an aggregate of 68,151,515 units were issued at a […]

June 24th, 2022

TORONTO, June 24, 2022 — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 28, 2022 prior to market open its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 […]

June 22nd, 2022

TORONTO, June 22, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is postponing the announcement of its fifth quarter and fiscal year results for the period ending March 31, 2022.  The Company shall provide a further update on the new date and earnings call details in due course.   […]

June 20th, 2022

Following final tabulation, Debentureholders pass Extraordinary Resolution approving Debenture Amendments Canceling Debentureholder meeting previously scheduled for June 23, 2022 TORONTO – June 20, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June […]

June 16th, 2022

Debentureholders have executed sufficient consents and proxies to approve Debenture Amendments TORONTO – June 16, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022 […]

June 15th, 2022

TORONTO, June 15, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 23 prior to market open its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. […]

June 2nd, 2022

Debentureholders representing approximately 61.4% of the Convertible Debentures outstanding have entered into Support Agreements[1], including each member of the Steering Committee nominated by Debentureholders Company more than 90% towards achieving a minimum of 66 2/3% required to pass the Debenture Amendments Debentureholders of record as of May 24, 2022 who provide valid consent and voting […]

May 24th, 2022

Adult-use cannabis market share increased three positions to 13th in April 2022 vs 16th in December 2021([1]) 53% increase in adult-use market share to 2.5% in April 2022 vs December 2021([2]), representing the 5th highest growth rate among the top 40 Canadian LPs Spring & Summer launch of 12 OCS and 8 AGLC SKUs builds […]

May 12th, 2022

Transforms the company’s balance sheet with an equity financing to fund growth and a favourable resolution to amend the key commercial terms of the Convertible Debentures Provides $11.6 million[1] in additional liquidity to fund working capital and growth initiatives and finance the company attaining break-even Adjusted EBITDA profitability in 2022[2] Augments the refinancing profile extending […]

April 28th, 2022

Holders representing approximately 62% of total Debentures extend Forbearance Period until May 12, 2022 to allow negotiations to continue   TORONTO – April 27, 2022 – Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on […]